India Pharma Outlook Team | Tuesday, 04 April 2023
Alniche Lifesciences, one of India's leading and fastest-growing pharmaceutical companies, has announced the expansion of its respiratory care footprints in order to increase its reach and impact. The upcoming respiratory product portfolio aims to provide effective solutions for a variety of respiratory conditions. "At Alniche, we are always looking for ways to improve patient outcomes and healthcare delivery.
We are excited to expand our critical care portfolio and provide innovative solutions that address unmet needs in respiratory, cardiovascular, and oncology care "said Girish Arora, MD and founder of Alniche Lifesciences. "Alniche's dedication to respiratory health stems from its mission to provide high-quality, innovative healthcare solutions to patients across India." We look forward to working with healthcare providers, patient advocacy groups, and other stakeholders to improve patient outcomes and advance healthcare as we expand our footprint in the respiratory segment," Arora added.